Phase I/II study of CPT-11 in combination with LV2FU5 (De Gramont-Regimen) every 2 weeks for the treatment of colorectal cancer (CRC) after 5FU failure

被引：0
|
作者：
Rougier, P
Ychou, M
Seitz, JF
Bonnay, M
Mignard, D
Couteau, C
Armand, JP
Ducreux, M
机构：
[1] IGR,VILLEJUIF,FRANCE
[2] CTR VAL AURELLE,MONTPELLIER,FRANCE
[3] INST J PAOLI I CALMETTES,F-13009 MARSEILLE,FRANCE
[4] RPR FRANCE,MONTROUGE,FRANCE
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：756 / 756
页数：1
相关论文
共 50 条
  • [1] Phase I/II study of CPT-II in combination with LV5FU2 (De Gramont-Regimen) every 2 weeks for the treatment of colorectal cancer (CRC) after 5-FU failure
    Seitz, JF
    Ducreux, M
    Ychou, M
    Bonnay, M
    Rougier, P
    Mignard, D
    Armand, JP
    ANNALS OF ONCOLOGY, 1998, 9 : 68 - 68
  • [2] A phase II study with 5-fluorouracil (5FU), leucovorin (LV) and irinotecan (CPT-11) in patients with metastatic colorectal cancer
    Destefanis, M
    Dalla Mola, A
    Ostellino, O
    Capello, C
    Milanesi, E
    Grillo, C
    Castiglione, F
    Venturino, A
    Porcile, G
    ANNALS OF ONCOLOGY, 2000, 11 : 67 - 67
  • [3] CPT-11 and L-OHP combination versus alternated combination of LV5FU2+CPT-11/LV5FU2+L-OHP in 5-FU resistant advanced colorectal cancer (CRC): Preliminary results
    Becouam, Y
    Mousseau, M
    Gamelin, E
    Coudert, B
    Marceau-Suissa, J
    Bekradda, M
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S71 - S71
  • [4] Phase I/II study of irinotecan (CPT-11) combined with 1-leucovorin (I-LV) and 5FU in patients with advanced colorectal cancer
    Komatsu, Y
    Takei, M
    Kato, T
    Miyagishima, T
    Kunieda, Y
    Tateyama, M
    Wakahama, O
    Takeda, H
    Kato, M
    Sugiyama, T
    Asaka, M
    Sakata, Y
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 437 - 437
  • [5] A phase I study of concomitant CPT-11 (C) and 5FU (F) combination: Preliminary results
    Rixe, O
    Benhammouda, A
    Farabos, C
    Borel, C
    Petit, T
    Auclerc, G
    Coeffic, D
    Bastian, G
    Grossin, F
    Paraiso, D
    Grapin, JP
    Nizri, D
    Weil, M
    Bismuth, H
    Mahjoubi, M
    Khayat, D
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 955 - 955
  • [6] A multicenter phase II study of irinotecan (CPT-11) and bolus 5-fluorouracil (5FU)/I-leucovorin (I-LV) in patients with metastatic colorectal cancer
    Fujishima, H
    Makiyama, A
    Miyanaga, O
    Ueda, A
    Esaki, T
    Mitsugi, K
    Baba, E
    Kusaba, H
    Harada, M
    Nakano, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 306S - 306S
  • [7] Sequential administration of 5-fluorouracil (5FU)/leucovorin (LV) followed by irinotecan (CPT-11) at relapse versus CPT-11 followed by 5-FU/LV in advanced colorectal carcinoma - A phase III randomized study
    Tsavaris, Nicolas
    Kosmas, Christos
    Skopelitis, Helias
    Papadoniou, Nicitas
    Polyzos, Aristidis
    Zografos, George
    Adoniou, Efstathios
    Gryniatsos, John
    Felekouras, Evangelos
    Zacharakis, Michalis
    Sigala, Francheska
    Bacoyiannis, Christos
    Papastratis, George
    Papalambros, Efstathios
    CHEMOTHERAPY, 2007, 53 (04) : 282 - 291
  • [8] 5-fluorouracil (5FU)/leucovorin (LV) followed by irinotecan (CPT-11) versus CPT-11 followed by 5-FU/LV at relapse in patients with advanced colorectal carcinoma. Phase III randomized study
    Tsavaris, N.
    Kosmas, C.
    Skopelitis, E.
    Papadoniou, N.
    Polyzos, A.
    Zografos, G.
    Diamartis, N.
    Ntokou, A.
    Tsaousi, S.
    Sarantonis, I
    Adoniou, E.
    Gryniatsos, J.
    Felekouras, E.
    Papalambros, E.
    ANNALS OF ONCOLOGY, 2008, 19 : 81 - 81
  • [9] A phase I study of bortezomib in combination with 5FU/LV plus oxaliplatin in patients (pts) with advanced colorectal cancer (CRC): EORTC 16029
    Lacombe, D. A.
    Caponigro, F.
    Anthoney, A.
    Bauer, J.
    Govaerts, A.
    Milano, A.
    Marreaud, S.
    Twelves, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] A phase II study of CPT 11 (irinotecan) in refractory to 5FU colorectal cancer with curative treatment of delayed diarrhea by Acetorphan
    Merrouche, Y
    Bugat, R
    Brunet, R
    Seitz, JF
    Conroy, T
    Fabre, V
    Namer, M
    Piolat, V
    Mahjoubi, M
    Droz, JP
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 759 - 759
12345